Root Financial Partners’s Aktis Oncology AKTS Stock Holding History

Root Financial Partners’s Portfolio AKTS Stock Details AKTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$117	Buy	+6	New	+$146	﹤0.01%	3617

Other funds holding AKTS

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

NLB Skladi upravljanje premozenja Ljubljana $2.71B AUM 53.8% 1-Year Est. Return

NBC Securities Birmingham, Alabama $1.47B AUM 20.38% 1-Year Est. Return

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

Root Financial Partners's AKTS Position: Q3 2026 in Review

Root Financial Partners opened a new position in Aktis Oncology (AKTS) in Q3 2026: 6 shares worth $117. The stake represents ﹤0.01% of the portfolio and ranks #3617 among its holdings.

15 funds tracked by Wall St. Rank hold AKTS as of Q3 2026.

Root Financial Partners held 6 shares of Aktis Oncology worth $117 as of Q3 2026.
Aktis Oncology was a new Root Financial Partners position in Q3 2026.
Aktis Oncology made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3617 holding.
15 funds tracked by Wall St. Rank held Aktis Oncology as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.